FDA.reportPublic FDA data

Avapro 300 MG Oral Tablet

RxCUI
153667
RxNorm name
Avapro 300 MG Oral Tablet
Display name
Avapro 300 MG Oral Tablet
Full name
Avapro 300 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AvaproIRBESARTANSanofi-Aventis U.S. LLC7885b2a8-be4e-48ab-8113-4e6ab791eb982026-08-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153667

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7885b2a8-be4e-48ab-8113-4e6ab791eb98Avapro 300 MG Oral Tablet [PSN] · irbesartan 300 MG Oral Tablet [Avapro] [SBD] · Avapro 300 MG Oral Tablet [SY]321These highlights do not include all the information needed to use AVAPRO safely and effectively. See full prescribing information for AVAPRO. AVAPRO ® (irbesartan) tablets, for oral use Initial U.S. Approval: 199720260219
4536ad0b-42f4-4bd1-83d4-467762291664Avapro 300 MG Oral Tablet [PSN] · irbesartan 300 MG Oral Tablet [Avapro] [SBD] · Avapro 300 MG Oral Tablet [SY]32AVAPRO ® (irbesartan) Tablets20111220